SEC Info℠  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Passage BIO, Inc. – ‘10-Q’ for 6/30/22 – ‘EX-101.CAL’

On:  Thursday, 8/4/22, at 7:15am ET   ·   For:  6/30/22   ·   Accession #:  1558370-22-12042   ·   File #:  1-39231

Previous ‘10-Q’:  ‘10-Q’ on 5/16/22 for 3/31/22   ·   Next:  ‘10-Q’ on 11/10/22 for 9/30/22   ·   Latest:  ‘10-Q’ on 5/14/24 for 3/31/24   ·   2 References:   

Find Words in Filings emoji
 		  in    Show  and   ↓Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 8/04/22  Passage BIO, Inc.                 10-Q        6/30/22   58:6.6M                                   Toppan Merrill Bridge/FA

Quarterly Report   —   Form 10-Q

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML   1.86M 
 2: EX-10.1     Material Contract                                   HTML     87K 
 3: EX-10.2     Material Contract                                   HTML     42K 
 4: EX-31.1     Certification -- §302 - SOA'02                      HTML     25K 
 5: EX-31.2     Certification -- §302 - SOA'02                      HTML     25K 
 6: EX-32.1     Certification -- §906 - SOA'02                      HTML     19K 
 7: EX-32.2     Certification -- §906 - SOA'02                      HTML     19K 
13: R1          Document and Entity Information                     HTML     73K 
14: R2          Balance Sheets                                      HTML    107K 
15: R3          Balance Sheets (Parenthetical)                      HTML     25K 
16: R4          Statements of Operations and Comprehensive Loss     HTML     71K 
17: R5          Statements of Stockholders' Equity                  HTML     84K 
18: R6          Statements of Stockholders' Equity (Parenthetical)  HTML     18K 
19: R7          Statements of Cash Flows                            HTML    103K 
20: R8          Nature of Operations                                HTML     21K 
21: R9          Risks and Liquidity                                 HTML     22K 
22: R10         Summary of Significant Accounting Policies          HTML     40K 
23: R11         Cash, cash equivalents and marketable securities    HTML    111K 
24: R12         Fair Value of Financial Instruments                 HTML    112K 
25: R13         Property and Equipment, net                         HTML     36K 
26: R14         Accrued Expenses and Other Current Liabilities      HTML     32K 
27: R15         Leases                                              HTML     54K 
28: R16         Commitments and Contingencies                       HTML     32K 
29: R17         Share-Based Compensation                            HTML     99K 
30: R18         Subsequent Events                                   HTML     20K 
31: R19         Summary of Significant Accounting Policies          HTML     61K 
                (Policies)                                                       
32: R20         Summary of Significant Accounting Policies          HTML     28K 
                (Tables)                                                         
33: R21         Cash, cash equivalents and marketable securities    HTML    112K 
                (Tables)                                                         
34: R22         Fair Value of Financial Instruments (Tables)        HTML    108K 
35: R23         Property and Equipment, net (Tables)                HTML     34K 
36: R24         Accrued Expenses and Other Current Liabilities      HTML     32K 
                (Tables)                                                         
37: R25         Leases (Tables)                                     HTML     49K 
38: R26         Share-Based Compensation (Tables)                   HTML     96K 
39: R27         Risks and Liquidity (Details)                       HTML     30K 
40: R28         Summary of Significant Accounting Policies          HTML     35K 
                (Details)                                                        
41: R29         Cash, cash equivalents and marketable securities -  HTML     31K 
                Portfolio of Cash and Cash Equivalents (Details)                 
42: R30         Cash, cash equivalents and marketable securities -  HTML     43K 
                Portfolio of Marketable Securities (Details)                     
43: R31         Fair Value of Financial Instruments (Details)       HTML     55K 
44: R32         Property and Equipment, net (Details)               HTML     39K 
45: R33         Accrued Expenses and Other Current Liabilities      HTML     30K 
                (Details)                                                        
46: R34         Leases (Details)                                    HTML     80K 
47: R35         Leases - Operating lease cost (Details)             HTML     26K 
48: R36         Commitments and Contingencies - Collaboration       HTML     65K 
                Agreements (Details)                                             
49: R37         Share-Based Compensation - Equity Incentive Plan &  HTML     62K 
                ESPP (Details)                                                   
50: R38         Share-Based Compensation - Share-based              HTML     28K 
                compensation expense (Details)                                   
51: R39         Share-Based Compensation - Stock Option Activity    HTML     67K 
                (Details)                                                        
52: R40         Share-Based Compensation - Assumptions Used in      HTML     25K 
                Determining Fair Value & Early exercise of Stock                 
                Options (Details)                                                
53: R41         Share-Based Compensation - Restricted Stock Units   HTML     46K 
                (Details)                                                        
56: XML         IDEA XML File -- Filing Summary                      XML     97K 
54: XML         XBRL Instance -- pasg-20220630x10q_htm               XML   1.41M 
55: EXCEL       IDEA Workbook of Financial Reports                  XLSX     92K 
 9: EX-101.CAL  XBRL Calculations -- pasg-20220630_cal               XML    116K 
10: EX-101.DEF  XBRL Definitions -- pasg-20220630_def                XML    316K 
11: EX-101.LAB  XBRL Labels -- pasg-20220630_lab                     XML    905K 
12: EX-101.PRE  XBRL Presentations -- pasg-20220630_pre              XML    597K 
 8: EX-101.SCH  XBRL Schema -- pasg-20220630                         XSD    121K 
57: JSON        XBRL Instance as JSON Data -- MetaLinks              270±   415K 
58: ZIP         XBRL Zipped Folder -- 0001558370-22-012042-xbrl      Zip    463K

‘EX-101.CAL’   —   XBRL Calculations — pasg-20220630_cal

This Exhibit is an XBRL XML File.

                                                                                                                                                                                
<?xml version="1.0" encoding="windows-1252"?>
<!-- XBRL document created with Toppan Merrill Bridge 9.6.8167.22744 -->
<!-- Based on XBRL 2.1 -->
<!-- Created on: 8/3/2022 10:50:16 PM -->
<!-- Modified on: 8/3/2022 10:50:16 PM -->
<link:linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance">
<roleRef xlink:type="simple" xlink:href="pasg-20220630.xsd#StatementBalanceSheets" roleURI="http://www.passagebio.com/role/StatementBalanceSheets"/>
<roleRef xlink:type="simple" xlink:href="pasg-20220630.xsd#StatementStatementsOfOperationsAndComprehensiveLoss" roleURI="http://www.passagebio.com/role/StatementStatementsOfOperationsAndComprehensiveLoss"/>
<roleRef xlink:type="simple" xlink:href="pasg-20220630.xsd#StatementStatementsOfCashFlows" roleURI="http://www.passagebio.com/role/StatementStatementsOfCashFlows"/>
<roleRef xlink:type="simple" xlink:href="pasg-20220630.xsd#DisclosureCashCashEquivalentsAndMarketableSecuritiesPortfolioOfMarketableSecuritiesDetails" roleURI="http://www.passagebio.com/role/DisclosureCashCashEquivalentsAndMarketableSecuritiesPortfolioOfMarketableSecuritiesDetails"/>
<roleRef xlink:type="simple" xlink:href="pasg-20220630.xsd#DisclosureFairValueOfFinancialInstrumentsDetails" roleURI="http://www.passagebio.com/role/DisclosureFairValueOfFinancialInstrumentsDetails"/>
<roleRef xlink:type="simple" xlink:href="pasg-20220630.xsd#DisclosurePropertyAndEquipmentNetDetails" roleURI="http://www.passagebio.com/role/DisclosurePropertyAndEquipmentNetDetails"/>
<roleRef xlink:type="simple" xlink:href="pasg-20220630.xsd#DisclosureAccruedExpensesAndOtherCurrentLiabilitiesDetails" roleURI="http://www.passagebio.com/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesDetails"/>
<roleRef xlink:type="simple" xlink:href="pasg-20220630.xsd#DisclosureLeasesDetails" roleURI="http://www.passagebio.com/role/DisclosureLeasesDetails"/>
<roleRef xlink:type="simple" xlink:href="pasg-20220630.xsd#DisclosureLeasesDetailss" roleURI="http://www.passagebio.com/role/DisclosureLeasesDetailss"/>
<calculationLink xlink:role="http://www.passagebio.com/role/StatementBalanceSheets" xlink:type="extended" xlink:title="00100 - Statement - Balance Sheets">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="us-gaap_OtherAssetsNoncurrent_637951638156491594"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_OtherAssetsNoncurrent_637951638156491594" order="1" use="optional" weight="1" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset_637951638156491594"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset_637951638156491594" order="2" use="optional" weight="1"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_637951638156491594"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_637951638156491594" order="3" use="optional" weight="1" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent_637951638156491594"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_AssetsCurrent_637951638156491594" order="4" use="optional" weight="1" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_637951638156491594"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent_637951638156491594" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_637951638156491594" order="1" use="optional" weight="1" priority="2"/>
<loc xlink:type="locator" xlink:href="pasg-20220630.xsd#pasg_PrepaidResearchAndDevelopmentAssetCurrent" xlink:label="pasg_PrepaidResearchAndDevelopmentAssetCurrent_637951638156491594"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent_637951638156491594" xlink:to="pasg_PrepaidResearchAndDevelopmentAssetCurrent_637951638156491594" order="2" use="optional" weight="1" priority="3"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_637951638156501606"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent_637951638156491594" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_637951638156501606" order="3" use="optional" weight="1" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_637951638156501606"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent_637951638156491594" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_637951638156501606" order="4" use="optional" weight="1" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity_637951638156501606"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_StockholdersEquity_637951638156501606" order="1" use="optional" weight="1" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_637951638156501606"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity_637951638156501606" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_637951638156501606" order="1" use="optional" weight="1" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_637951638156501606"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity_637951638156501606" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_637951638156501606" order="2" use="optional" weight="1" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="us-gaap_AdditionalPaidInCapital_637951638156501606"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity_637951638156501606" xlink:to="us-gaap_AdditionalPaidInCapital_637951638156501606" order="3" use="optional" weight="1" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue_637951638156501606"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity_637951638156501606" xlink:to="us-gaap_CommonStockValue_637951638156501606" order="4" use="optional" weight="1" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities_637951638156501606"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_Liabilities_637951638156501606" order="2" use="optional" weight="1" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent_637951638156511592"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities_637951638156501606" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent_637951638156511592" order="1" use="optional" weight="1"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredRentCreditNoncurrent" xlink:label="us-gaap_DeferredRentCreditNoncurrent_637951638156511592"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities_637951638156501606" xlink:to="us-gaap_DeferredRentCreditNoncurrent_637951638156511592" order="2" use="optional" weight="1" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent_637951638156511592"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities_637951638156501606" xlink:to="us-gaap_LiabilitiesCurrent_637951638156511592" order="3" use="optional" weight="1" priority="2"/>
<loc xlink:type="locator" xlink:href="pasg-20220630.xsd#pasg_AccruedExpensesAndOtherCurrentLiabilities" xlink:label="pasg_AccruedExpensesAndOtherCurrentLiabilities_637951638156511592"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent_637951638156511592" xlink:to="pasg_AccruedExpensesAndOtherCurrentLiabilities_637951638156511592" order="1" use="optional" weight="1" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent_637951638156511592"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent_637951638156511592" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent_637951638156511592" order="2" use="optional" weight="1"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="us-gaap_AccountsPayableCurrent_637951638156511592"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent_637951638156511592" xlink:to="us-gaap_AccountsPayableCurrent_637951638156511592" order="3" use="optional" weight="1" priority="2"/>
</calculationLink>
<calculationLink xlink:role="http://www.passagebio.com/role/StatementStatementsOfOperationsAndComprehensiveLoss" xlink:type="extended" xlink:title="00200 - Statement - Statements of Operations and Comprehensive Loss">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss_637951638156521592"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="us-gaap_NetIncomeLoss_637951638156521592" order="1" use="optional" weight="1" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeNet" xlink:label="us-gaap_InvestmentIncomeNet_637951638156521592"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLoss_637951638156521592" xlink:to="us-gaap_InvestmentIncomeNet_637951638156521592" order="1" use="optional" weight="1" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss_637951638156521592"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLoss_637951638156521592" xlink:to="us-gaap_OperatingIncomeLoss_637951638156521592" order="2" use="optional" weight="1" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="us-gaap_GeneralAndAdministrativeExpense_637951638156521592"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingIncomeLoss_637951638156521592" xlink:to="us-gaap_GeneralAndAdministrativeExpense_637951638156521592" order="1" use="optional" weight="-1" priority="3"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff" xlink:label="us-gaap_ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff_637951638156521592"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingIncomeLoss_637951638156521592" xlink:to="us-gaap_ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff_637951638156521592" order="2" use="optional" weight="-1" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" xlink:label="us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_637951638156521592"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingIncomeLoss_637951638156521592" xlink:to="us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_637951638156521592" order="3" use="optional" weight="-1" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax" xlink:label="us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax_637951638156521592"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax_637951638156521592" order="2" use="optional" weight="1" priority="2"/>
</calculationLink>
<calculationLink xlink:role="http://www.passagebio.com/role/StatementStatementsOfCashFlows" xlink:type="extended" xlink:title="00400 - Statement - Statements of Cash Flows">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_637951638156531594"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_637951638156531594" order="1" use="optional" weight="1" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="us-gaap_ProceedsFromStockOptionsExercised_637951638156531594"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities_637951638156531594" xlink:to="us-gaap_ProceedsFromStockOptionsExercised_637951638156531594" order="1" use="optional" weight="1" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockPlans" xlink:label="us-gaap_ProceedsFromStockPlans_637951638156531594"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities_637951638156531594" xlink:to="us-gaap_ProceedsFromStockPlans_637951638156531594" order="2" use="optional" weight="1" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts_637951638156531594"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities_637951638156531594" xlink:to="us-gaap_PaymentsOfStockIssuanceCosts_637951638156531594" order="3" use="optional" weight="-1" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_637951638156531594"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities_637951638156531594" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock_637951638156531594" order="4" use="optional" weight="1" priority="2"/>
<loc xlink:type="locator" xlink:href="pasg-20220630.xsd#pasg_PaymentsForInsurancePremiumFinancing" xlink:label="pasg_PaymentsForInsurancePremiumFinancing_637951638156531594"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities_637951638156531594" xlink:to="pasg_PaymentsForInsurancePremiumFinancing_637951638156531594" order="5" use="optional" weight="-1"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_637951638156531594"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_637951638156531594" order="2" use="optional" weight="1" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireMarketableSecurities" xlink:label="us-gaap_PaymentsToAcquireMarketableSecurities_637951638156531594"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities_637951638156531594" xlink:to="us-gaap_PaymentsToAcquireMarketableSecurities_637951638156531594" order="1" use="optional" weight="-1" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:label="us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_637951638156531594"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities_637951638156531594" xlink:to="us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_637951638156531594" order="2" use="optional" weight="1" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireMachineryAndEquipment" xlink:label="us-gaap_PaymentsToAcquireMachineryAndEquipment_637951638156531594"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities_637951638156531594" xlink:to="us-gaap_PaymentsToAcquireMachineryAndEquipment_637951638156531594" order="3" use="optional" weight="-1" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireIntangibleAssets" xlink:label="us-gaap_PaymentsToAcquireIntangibleAssets_637951638156541599"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities_637951638156531594" xlink:to="us-gaap_PaymentsToAcquireIntangibleAssets_637951638156541599" order="4" use="optional" weight="-1" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_637951638156541599"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_637951638156541599" order="3" use="optional" weight="1" priority="2"/>
<loc xlink:type="locator" xlink:href="pasg-20220630.xsd#pasg_IncreaseDecreaseInAccruedExpensesAndOtherCurrentLiabilities" xlink:label="pasg_IncreaseDecreaseInAccruedExpensesAndOtherCurrentLiabilities_637951638156541599"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities_637951638156541599" xlink:to="pasg_IncreaseDecreaseInAccruedExpensesAndOtherCurrentLiabilities_637951638156541599" order="1" use="optional" weight="1" priority="2"/>
<loc xlink:type="locator" xlink:href="pasg-20220630.xsd#pasg_IncreaseDecreaseInRightOfUseAssetsAndOperatingLeaseLiabilities" xlink:label="pasg_IncreaseDecreaseInRightOfUseAssetsAndOperatingLeaseLiabilities_637951638156541599"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities_637951638156541599" xlink:to="pasg_IncreaseDecreaseInRightOfUseAssetsAndOperatingLeaseLiabilities_637951638156541599" order="2" use="optional" weight="-1"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableTrade" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableTrade_637951638156541599"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities_637951638156541599" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayableTrade_637951638156541599" order="3" use="optional" weight="1" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_637951638156541599"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities_637951638156541599" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_637951638156541599" order="4" use="optional" weight="-1" priority="3"/>
<loc xlink:type="locator" xlink:href="pasg-20220630.xsd#pasg_IncreaseDecreaseInPrepaidResearchAndDevelopment" xlink:label="pasg_IncreaseDecreaseInPrepaidResearchAndDevelopment_637951638156541599"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities_637951638156541599" xlink:to="pasg_IncreaseDecreaseInPrepaidResearchAndDevelopment_637951638156541599" order="5" use="optional" weight="-1" priority="2"/>
<loc xlink:type="locator" xlink:href="pasg-20220630.xsd#pasg_IncreaseDecreaseInDeferredRent" xlink:label="pasg_IncreaseDecreaseInDeferredRent_637951638156541599"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities_637951638156541599" xlink:to="pasg_IncreaseDecreaseInDeferredRent_637951638156541599" order="6" use="optional" weight="1" priority="4"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfDebtDiscountPremium" xlink:label="us-gaap_AmortizationOfDebtDiscountPremium_637951638156551598"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities_637951638156541599" xlink:to="us-gaap_AmortizationOfDebtDiscountPremium_637951638156551598" order="7" use="optional" weight="1" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="us-gaap_ShareBasedCompensation_637951638156551598"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities_637951638156541599" xlink:to="us-gaap_ShareBasedCompensation_637951638156551598" order="8" use="optional" weight="1" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="us-gaap_DepreciationDepletionAndAmortization_637951638156551598"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities_637951638156541599" xlink:to="us-gaap_DepreciationDepletionAndAmortization_637951638156551598" order="9" use="optional" weight="1" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff" xlink:label="us-gaap_ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff_637951638156551598"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities_637951638156541599" xlink:to="us-gaap_ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff_637951638156551598" order="10" use="optional" weight="1" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss_637951638156551598"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities_637951638156541599" xlink:to="us-gaap_NetIncomeLoss_637951638156551598" order="11" use="optional" weight="1" priority="2"/>
</calculationLink>
<calculationLink xlink:role="http://www.passagebio.com/role/DisclosureCashCashEquivalentsAndMarketableSecuritiesPortfolioOfMarketableSecuritiesDetails" xlink:type="extended" xlink:title="40402 - Disclosure - Cash, cash equivalents and marketable securities - Portfolio of Marketable Securities (Details)">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_637951638156561600"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_637951638156561600" order="1" use="optional" weight="-1" priority="3"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_637951638156561600"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_637951638156561600" order="2" use="optional" weight="1" priority="5"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecurities_637951638156561600"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtSecurities_637951638156561600" order="3" use="optional" weight="1" priority="2"/>
</calculationLink>
<calculationLink xlink:role="http://www.passagebio.com/role/DisclosureFairValueOfFinancialInstrumentsDetails" xlink:type="extended" xlink:title="40501 - Disclosure - Fair Value of Financial Instruments (Details)">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsFairValueDisclosure" xlink:label="us-gaap_AssetsFairValueDisclosure"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:label="us-gaap_CashAndCashEquivalentsFairValueDisclosure_637951638156561600"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsFairValueDisclosure" xlink:to="us-gaap_CashAndCashEquivalentsFairValueDisclosure_637951638156561600" order="1" use="optional" weight="1" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecurities_637951638156561600"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsFairValueDisclosure" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtSecurities_637951638156561600" order="2" use="optional" weight="1" priority="2"/>
</calculationLink>
<calculationLink xlink:role="http://www.passagebio.com/role/DisclosurePropertyAndEquipmentNetDetails" xlink:type="extended" xlink:title="40601 - Disclosure - Property and Equipment, net (Details)">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_637951638156561600"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_637951638156561600" order="1" use="optional" weight="-1"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="us-gaap_PropertyPlantAndEquipmentGross_637951638156561600"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentGross_637951638156561600" order="2" use="optional" weight="1"/>
</calculationLink>
<calculationLink xlink:role="http://www.passagebio.com/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesDetails" xlink:type="extended" xlink:title="40701 - Disclosure - Accrued Expenses and Other Current Liabilities (Details)">
<loc xlink:type="locator" xlink:href="pasg-20220630.xsd#pasg_AccruedExpensesAndOtherCurrentLiabilities" xlink:label="pasg_AccruedExpensesAndOtherCurrentLiabilities"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedProfessionalFeesCurrent" xlink:label="us-gaap_AccruedProfessionalFeesCurrent_637951638156571596"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="pasg_AccruedExpensesAndOtherCurrentLiabilities" xlink:to="us-gaap_AccruedProfessionalFeesCurrent_637951638156571596" order="1" use="optional" weight="1" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent_637951638156571596"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="pasg_AccruedExpensesAndOtherCurrentLiabilities" xlink:to="us-gaap_EmployeeRelatedLiabilitiesCurrent_637951638156571596" order="2" use="optional" weight="1" priority="2"/>
<loc xlink:type="locator" xlink:href="pasg-20220630.xsd#pasg_AccruedResearchAndDevelopmentExpense" xlink:label="pasg_AccruedResearchAndDevelopmentExpense_637951638156571596"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="pasg_AccruedExpensesAndOtherCurrentLiabilities" xlink:to="pasg_AccruedResearchAndDevelopmentExpense_637951638156571596" order="3" use="optional" weight="1" priority="2"/>
<loc xlink:type="locator" xlink:href="pasg-20220630.xsd#pasg_AccruedLiabilitiesPropertyAndEquipmentCurrent" xlink:label="pasg_AccruedLiabilitiesPropertyAndEquipmentCurrent_637951638156571596"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="pasg_AccruedExpensesAndOtherCurrentLiabilities" xlink:to="pasg_AccruedLiabilitiesPropertyAndEquipmentCurrent_637951638156571596" order="4" use="optional" weight="1" priority="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="us-gaap_OtherLiabilitiesCurrent_637951638156571596"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="pasg_AccruedExpensesAndOtherCurrentLiabilities" xlink:to="us-gaap_OtherLiabilitiesCurrent_637951638156571596" order="5" use="optional" weight="1" priority="2"/>
</calculationLink>
<calculationLink xlink:role="http://www.passagebio.com/role/DisclosureLeasesDetails" xlink:type="extended" xlink:title="40801 - Disclosure - Leases (Details)">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_637951638156571596"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_637951638156571596" order="1" use="optional" weight="1"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_637951638156571596"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_637951638156571596" order="2" use="optional" weight="1"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_637951638156581596"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_637951638156581596" order="3" use="optional" weight="1"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_637951638156581596"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_637951638156581596" order="4" use="optional" weight="1"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_637951638156581596"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_637951638156581596" order="5" use="optional" weight="1"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_637951638156581596"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_637951638156581596" order="6" use="optional" weight="1"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_637951638156581596"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_637951638156581596" order="7" use="optional" weight="1"/>
<loc xlink:type="locator" xlink:href="pasg-20220630.xsd#pasg_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour" xlink:label="pasg_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour_637951638156581596"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="pasg_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour_637951638156581596" order="8" use="optional" weight="1"/>
</calculationLink>
<calculationLink xlink:role="http://www.passagebio.com/role/DisclosureLeasesDetailss" xlink:type="extended" xlink:title="40801 - Disclosure - Leases (Details)">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_1"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_637951638156581596"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_1" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_637951638156581596" order="1" use="optional" weight="1"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability" xlink:label="us-gaap_OperatingLeaseLiability_637951638156581596"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_1" xlink:to="us-gaap_OperatingLeaseLiability_637951638156581596" order="2" use="optional" weight="1"/>
</calculationLink>
</link:linkbase>

2 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 3/04/24  Passage BIO, Inc.                 10-K       12/31/23   73:10M                                    Toppan Merrill Bridge/FA
 3/06/23  Passage BIO, Inc.                 10-K       12/31/22   70:9M                                     Toppan Merrill Bridge/FA
↑Top
Filing Submission 0001558370-22-012042   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)
Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
About — Privacy — Redactions — Help — Fri., May 17, 7:58:59.2pm ET